TIDM0Y4Q
RNS Number : 3445G
J.P. Morgan Securities LLC
23 July 2021
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing J.P. Morgan Securities
(Note 1) LLC
Company dealt in Willis Towers Watson plc
========================
Class of relevant security US$0.000304635 ordinary
to which the dealings shares
being disclosed relate
(Note 2)
========================
Date of dealing 22 July 2021
========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
======= ==== ==== ========= ==== ====
(1) Relevant securities 1,796,285 1.39 1,760,041 1.36
------------------- ---------------------
(2) Derivatives (other
than options) 1,609,191 1.25 1,641,400 1.27
------------------- ---------------------
(3) Options and agreements
to purchase/sell 2,000 0.00 26,000 0.02
------------------- ---------------------
Total 3,407,476 2.64 3,427,441 2.65
------------------- ---------------------
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(USD)
(Note 5)
Purchase (New 100 N/A
Borrow)
35 224.6200 USD
Purchases 1 226.5800 USD
Purchases 3 226.3967 USD
Purchases 1 226.1800 USD
Purchases 3 226.5167 USD
Purchases 4 226.4625 USD
Purchases 207 226.3400 USD
Purchases 4 226.2600 USD
Purchases 4 226.1525 USD
Purchases 1 226.4400 USD
Purchases 4 225.9300 USD
Purchases 2 226.6500 USD
Purchases 8,100 226.3282 USD
Purchases 2 226.3600 USD
Purchases 700 226.3214 USD
Purchases 216 226.5561 USD
Purchases 100 226.4643 USD
Purchases 7,084 226.3143 USD
Purchases 50,272 226.2519 USD
Purchases 2 226.2850 USD
Purchases 1 226.7300 USD
Purchases 2 226.4850 USD
Purchases 2 226.1750 USD
Purchases
35 224.6200 USD
Sales 5 226.2200 USD
Sales 127 226.5700 USD
Sales 6,734 226.3400 USD
Sales 86 226.4400 USD
Sales 1 226.3275 USD
Sales 733 226.2817 USD
Sales 497 225.9495 USD
Sales 1,013 226.2705 USD
Sales 965 226.0315 USD
Sales 84 225.9400 USD
Sales 24 226.6400 USD
Sales 1,038 226.2744 USD
Sales 10 226.2650 USD
Sales 86 225.9300 USD
Sales 10 226.0750 USD
Sales 130 226.0900 USD
Sales 4 226.1300 USD
Sales 833 226.3321 USD
Sales 2,173 226.2822 USD
Sales 670 226.0275 USD
Sales 196 226.2603 USD
Sales 86 226.6800 USD
Sales 1,078 226.1563 USD
Sales 3,647 226.1458 USD
Sales 613 226.4184 USD
Sales 736 226.1347 USD
Sales 174 226.0700 USD
Sales 32 226.2100 USD
Sales 4 226.1000 USD
Sales 81 226.0600 USD
Sales 88 226.0800 USD
Sales 202 226.5085 USD
Sales 6 226.1500 USD
Sales 79 226.8200 USD
Sales 86 225.9100 USD
Sales 87 226.0000 USD
Sales 56 226.1400 USD
Sales 245 226.1100 USD
Sales 274 226.7208 USD
Sales 5 226.4000 USD
Sales 109 226.6500 USD
Sales 385 226.6851 USD
Sales 354 226.7548 USD
Sales 26 226.6700 USD
Sales 1 226.7750 USD
Sales 10 226.6450 USD
Sales 12 226.6600 USD
Sales 87 226.0500 USD
Sales 265 226.2167 USD
Sales 109 226.4412 USD
Sales 831 226.0247 USD
Sales 54 226.5000 USD
Sales 8,100 226.3282 USD
Sales 5 225.8200 USD
Sales 25 226.3600 USD
Sales 50,272 226.2519 USD
Sales 428 226.1581 USD
Sales 1 226.9850 USD
Sales 26 226.3100 USD
Sales 136 226.5920 USD
Sales 33 226.1600 USD
Sales 88 226.2300 USD
Sales 40 226.6150 USD
Sales 1 226.5300 USD
Sales 633 226.6706 USD
Sales 1,460 226.6277 USD
Sales 11 226.6250 USD
Sales 182 226.2766 USD
Sales 63 225.8500 USD
Sales 3,504 226.1518 USD
Sales
====================================== ====================
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant Price per
e.g. CFD (Note 6) securities unit
(Note 7) (USD) (Note
5)
Equity Swap Decrease Short 25,136 226.2469
USD
Increase Long 6,400
226.3400
Increase Short 8,100 USD
Decrease Long 2 226.3282
USD
226.3604
USD
===================== ================== =============
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money
e.g. call purchasing, to which (USD) European paid/received
option varying the option etc. per unit
etc. relates (Note (Note
7) 5) (USD)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) Yes
Date of disclosure 23 July 2021
Contact name Alwyn Basch
=============
Telephone number 0207 742 7407
=============
If a connected EFM, name N/A
of offeree/offeror with
which connected
=============
If a connected EFM, state N/A
nature of connection (Note
10)
=============
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form
8.1(b)(ii) or Form 8.3,
as appropriate)
OPEN POSITIONS (Note 1)
Product Written, Number of relevant Exercise Type, e.g. Expiry
name, or purchased securities price American, date
e.g. call to which the (Note European
option option or derivative 2) (USD) etc.
relates
Call Option Purchased 2,000 230.00 American 17/09/2021
Call Option Written 2,000 230.00 American 20/08/2021
Put Option Written 24,000 220.00 American 20/08/2021
============== ====================== ========= ========== ===========
Notes
1. Where there are open option positions or open derivative
positions (except for CFDs), full details should be given. Full
details of any existing agreements to purchase or to sell must also
be
given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosur e requirements, see Rule 8 of the
Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ISEZXLFLFDLFBBV
(END) Dow Jones Newswires
July 23, 2021 10:21 ET (14:21 GMT)
Willis Towers Watson (LSE:0Y4Q)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Willis Towers Watson (LSE:0Y4Q)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
